1-10 of 10
Michael T Hemmer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Outcomes of Brexucabtagene Autoleucel (Brexu-cel) for Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL): A CIBMTR Subgroup Analysis of High-Risk Characteristics

Swetha Kambhampati, Nausheen Ahmed, Mehdi Hamadani, Soyoung Kim, Michael T. Hemmer, Natalie S. Grover, Mazyar Shadman, Amer Beitinjaneh, L. Elizabeth Budde, James Gerson, Caron A. Jacobson, Frederick L. Locke, Dwivedy S. Nasta, Michael L. Wang, Wen-Kai Weng, Jiali Yan, Ana Nunes, David Dalton, James J. Wu, Amina Abdeldaim, Zhen-Huan Hu, Marcelo Pasquini, Alex F. Herrera
Journal: Blood
Blood (2023) 142 (Supplement 1): 107.
https://doi.org/10.1182/blood-2023-179269
Published: 2023
Journal Articles

A Real-World Evidence Comparison of 1-Year Overall Survival and Relapse-Free Survival between Patients Treated with Abatacept in Combination with a Calcineurin Inhibitor and Methotrexate Versus Antithymocyte Globulin or Post-Transplant Cyclophosphamide Following Allogeneic Hematopoietic Cell Transplantation

Leslie S. Kean, Linda J Burns, Tzuyung Douglas Kou, Christopher Bond, Roxanne Kapikian, Karissa Lozenski, Xiao-Ying Tang, Mei-Jie Zhang, Michael T Hemmer, Sean E Connolly, Martin Polinsky, Andres Gomez, Marcelo C Pasquini
Journal: Blood
Blood (2022) 140 (Supplement 1): 1373–1375.
https://doi.org/10.1182/blood-2022-157610
Published: 2022
Journal Articles

Veno-Occlusive Disease Risk and Other Outcomes in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia Who Received Inotuzumab Ozogamicin and Proceeded to Hematopoietic Stem Cell Transplantation: A Registry-Based, Observational Study

Marcos J.G. de Lima, Partow Kebriaei, Francesco Lanza, Christina Cho, Gizelle Popradi, Michael T Hemmer, Mei-Jie Zhang, Fan Zhang, Richa Shah, Verna Welch, Saara Tikka, Erik Vandendries, Matthias Stelljes, David I. Marks, Wael Saber
Journal: Blood
Blood (2022) 140 (Supplement 1): 6023–6025.
https://doi.org/10.1182/blood-2022-160315
Published: 2022
Journal Articles

Early Broad-Spectrum Antibiotics and Risk of Acute Graft-Versus-Host Disease in Children: An Analysis from the Center for International Blood and Marrow Transplantation Research (CIBMTR) and the Pediatric Health Information System (PHIS)

Caitlin W Elgarten, MD MSc, Yimei Li, PhD, Yuan-Shung V. Huang, MS, Richard Aplenc, MD PhD, Michael T. Hemmer, MS, Mukta Arora, MD, Stephen R. Spellman, MS, Tao Wang, PhD, Madan Jagasia, MBBS, MS, MMHC, Margaret L. MacMillan, MD, Joseph Pidala, MD, Brian T. Fisher, DO, MSCE, Matt Hall, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 599.
https://doi.org/10.1182/blood-2019-130466
Published: 2019
Journal Articles

Impact of T-Cell Dose on Gvhd Risk after Allogeneic HLA-Matched PBSC Transplantation

Ayman Saad, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Stephen R. Spellman, Mukta Arora, MD, Lawrence S. Lamb, Jr., PhD, Shahrukh K. Hashmi, MD MPH
Journal: Blood
Blood (2018) 132 (Supplement 1): 3410.
https://doi.org/10.1182/blood-2018-99-113513
Published: 2018
Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes

Mary Eapen, MBBS, MS, Ruta Brazauskas, PhD, Michael T. Hemmer, MS, Waleska S Pérez, MPH, Patricia Steinart, PhD, Mary M. Horowitz, MD MS, H. Joachim Deeg, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 598.
https://doi.org/10.1182/blood.V130.Suppl_1.598.598
Published: 2017
Journal Articles

Graft-Versus-Host Disease (GVHD)-Free Relapse-Free Survival (GRFS) and Chronic Gvhd (CRFS) in Alternative Donor Hematopoietic Cell Transplantation (HCT) in Pediatric Patients

Rohtesh S. Mehta, MDMPH,MS, Shernan G. Holtan, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Stephen R. Spellman, Mukta Arora, MD, Daniel R. Couriel, MD, Amin M. Alousi, Joseph Pidala, MD PhD, Daniel J. Weisdorf, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2053.
https://doi.org/10.1182/blood.V130.Suppl_1.2053.2053
Published: 2017
Journal Articles

Graft-Versus-Host Disease (GVHD)-Free Relapse-Free Survival (GRFS) and Chronic Gvhd (CRFS) in Alternative Donor Hematopoietic Cell Transplantation (HCT) in Adults

Rohtesh S. Mehta, MDMPH,MS, Shernan G. Holtan, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Stephen R. Spellman, Mukta Arora, MD, Daniel R. Couriel, MD, Amin M. Alousi, Joseph Pidala, MD PhD, Daniel J. Weisdorf, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 517.
https://doi.org/10.1182/blood.V130.Suppl_1.517.517
Published: 2017
Journal Articles

Comparison of Tacrolimus Versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: A CIBMTR Analysis

Yoshihiro Inamoto, MD PhD, Paul J. Martin, MD, Mary E. Flowers, MD, Alvaro Urbano-Ispizua, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Corey S Cutler, MD MPH, Daniel R. Couriel, MD, Amin M. Alousi, MD, Mukta Arora, MD MS, Stephen R. Spellman, MBS
Journal: Blood
Blood (2014) 124 (21): 4383.
https://doi.org/10.1182/blood.V124.21.4383.4383
Published: 2014
Journal Articles

The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort

Mary E. D. Flowers, MD, John P. Klein, PhD, Michael T. Hemmer, MS, Peigang Li, MS, Corey S. Cutler, MD, Alvaro Urbano-Ispizua, MD, Daniel R. Couriel, MD, Robert Peter Gale, MD, PhD, DSc, FACP, Yoshihiro Inamoto, MD, PhD, Joseph H. Antin, MD, Brian J. Bolwell, MD, Michael Boyiadzis, MD, MHSc, Jean-Yves Cahn, MD, Mitchell S. Cairo, MD, Luis M. Isola, MD, David A. Jacobsohn, MD, Madan Jagasia, MBBS, MS, Thomas R. Klumpp, MD, Effie W. Petersdorf, MD, Stella Santarone, MD, Harry C. Schouten, MD, PhD, John R. Wingard, MD, PhD, Stephen Spellman, MBS, Daniel J. Weisdorf, MD, Steven Z. Pavletic, MD, Stephanie J. Lee, MD, MPH, Mary M. Horowitz, MD, MS, Mukta Arora, MD, MS
Journal: Blood
Blood (2013) 122 (21): 706.
https://doi.org/10.1182/blood.V122.21.706.706
Published: 2013